Anastassiades E, Howarth D, Howarth J, Shanks D, Waters H, Hyde K, Yin J L, Geary C, Gokal R
Department of Renal Medicine, Manchester Royal Infirmary, UK.
Nephrol Dial Transplant. 1993;8(7):621-5.
Twenty-seven patients with renal failure (16 on CAPD and 11 predialysis) were treated with erythropoietin. At 12 weeks, the mean haemoglobin concentration (+/- SEM) in the CAPD patients had increased from 7.07 +/- 0.20 to 10.88 +/- 0.45 g/dl (two-tailed paired t test, P < 0.0001) and in the predialysis patients from 6.90 +/- 0.35 to 10.05 +/- 0.47 g/dl (P < 0.0001). Predialysis patients were taking more antihypertensive medication at baseline. No increase was required in either group after erythropoietin; there was no change in blood pressure in the CAPD patients, though in the predialysis patients the systolic blood pressure rose slightly from 132 to 146 mmHg (P = 0.029) and the mean blood pressure from 95 to 103 mmHg (P = 0.028). In 12 patients (6 on CAPD and 6 predialysis) the red cell volume, plasma volume, and total blood volume were measured before and after treatment. In the CAPD patients there was a marked expansion of the red cell volume from 912 +/- 127 to 1471 +/- 222 ml (P = 0.004) and a concomitant contraction of the plasma volume from 3932 +/- 250 to 3178 +/- 326 ml (P = 0.005), leaving the blood volume unchanged from 4843 +/- 352 to 4649 +/- 503 ml. Predialysis patients had a similar expansion of the red cell volume from 733 +/- 59 to 1304 +/- 161 ml (P = 0.017) but no contraction of the plasma volume (from 3417 +/- 354 to 3314 +/- 260 ml), so that the blood volume tended to expand from 4149 +/- 347 to 4618 +/- 414 ml (P = 0.053).(ABSTRACT TRUNCATED AT 250 WORDS)
27例肾衰竭患者(16例接受持续性非卧床腹膜透析,11例处于透析前阶段)接受了促红细胞生成素治疗。12周时,持续性非卧床腹膜透析患者的平均血红蛋白浓度(±标准误)从7.07±0.20g/dl增至10.88±0.45g/dl(双侧配对t检验,P<0.0001),透析前患者的平均血红蛋白浓度从6.90±0.35g/dl增至10.05±0.47g/dl(P<0.0001)。透析前患者在基线时服用更多的抗高血压药物。促红细胞生成素治疗后两组均无需增加药物剂量;持续性非卧床腹膜透析患者的血压无变化,而透析前患者的收缩压从132mmHg轻度升至146mmHg(P=0.029),平均血压从95mmHg升至103mmHg(P=0.028)。对12例患者(6例持续性非卧床腹膜透析患者和6例透析前患者)在治疗前后测量了红细胞体积、血浆体积和总血容量。持续性非卧床腹膜透析患者的红细胞体积从912±127ml显著增至1471±222ml(P=0.004),同时血浆体积从3932±250ml收缩至3178±326ml(P=0.005),血容量从4843±352ml至4649±503ml无变化。透析前患者的红细胞体积从733±59ml有类似的增加至1304±161ml(P=0.017),但血浆体积无收缩(从3417±354ml至3314±260ml),因此血容量倾向于从4149±347ml增至4618±414ml(P=0.053)。(摘要截短于250词)